{{Distinguish2|[[Sepazon]] or [[Sibazon]], a brand name for [[diazepam]] in Russia)}}

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 455325466
| IUPAC_name = 10-chloro-11''b''-(2-chlorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-''d''][1,4]benzodiazepin-6-one
| image = File:Cloxazolam.svg
| width = 150
| image2 = Cloxazolam-3d-model.png

<!--Clinical data-->
| tradename = Sepazon, Olcadil, Akton, Lubalix
| Drugs.com = {{drugs.com|international|cloxazolam}}
| pregnancy_category =
| legal_CA = Schedule IV
| legal_DE = Anlage III
| legal_UK = Class C
| legal_US = Schedule IV
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism = [[Liver|Hepatic]]
| elimination_half-life = 65 hours
| excretion = [[Kidney|Renal]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 24166-13-0
| ATC_prefix = N05
| ATC_suffix = BA22
| PubChem = 2816
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2107254
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01553
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2714
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = GYL649Z0HY
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01268

<!--Chemical data-->
| C=17 | H=14 | Cl=2 | N=2 | O=2 
| molecular_weight = 349.2 g/mol
| smiles = Clc1ccccc1C42OCCN2CC(=O)Nc3c4cc(Cl)cc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H14Cl2N2O2/c18-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)19)21(7-8-23-17)10-16(22)20-15/h1-6,9H,7-8,10H2,(H,20,22)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZIXNZOBDFKSQTC-UHFFFAOYSA-N
}}

'''Cloxazolam'''<ref>DE Patent 1817923</ref> (marketed under the brand names '''Sepazon''', '''Olcadil''' (Brazil, Portugal and Spain), '''Akton''' (Belgium), and '''Lubalix''' (Switzerland)) is a drug which is a [[benzodiazepine]] derivative.<ref>{{cite web|url=http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html |title=Benzodiazepine Names |accessdate=2008-12-29 |publisher=non-benzodiazepines.org.uk |deadurl=yes |archiveurl=https://web.archive.org/web/20081208054743/http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html |archivedate=2008-12-08 |df= }}</ref> Cloxazolam is metabolised into the [[active metabolite]] [[chlordesmethyldiazepam]] (delorazepam).<ref>{{Cite journal | last1 = Oliveira-Silva | first1 = D. | last2 = Oliveira | first2 = CH. | last3 = Mendes | first3 = GD. | last4 = Galvinas | first4 = PA. | last5 = Barrientos-Astigarraga | first5 = RE. | last6 = De Nucci | first6 = G. | title = Quantification of chlordesmethyldiazepam by liquid chromatography-tandem mass spectrometry: application to a cloxazolam bioequivalence study. | journal = Biomed Chromatogr | volume = 23 | issue = 12 | pages = 1266–75 |date=Dec 2009 | doi = 10.1002/bmc.1249 | pmid = 19488979 }}</ref> It possesses [[anxiolytic]],<ref>{{Cite journal | last1 = Kamioka | first1 = T. | last2 = Nakayama | first2 = I. | last3 = Akiyama | first3 = S. | last4 = Takagi | first4 = H. | title = Effects of oxazolam, cloxazolam, and CS-386, new anti-anxiety drugs, on socially induced suppression and aggression in pairs of monkeys. | journal = Psychopharmacology | volume = 52 | issue = 1 | pages = 17–23 |date=Mar 1977 | doi =  10.1007/BF00426594| pmid = 15296 }}</ref> [[anticonvulsant]],<ref>{{Cite journal  | last1 = Ito | first1 = M. | last2 = Miyajima | first2 = T. | last3 = Fujii | first3 = T. | last4 = Okuno | first4 = T. | title = Cloxazolam treatment for patients with intractable epilepsy. | journal = Pediatr Neurol | volume = 30 | issue = 2 | pages = 111–4 |date=Feb 2004 | doi = 10.1016/j.pediatrneurol.2003.07.004 | pmid = 14984903 }}</ref> [[hypnotic]],<ref>{{Cite journal  | last1 = Inoue | first1 = H. | last2 = Maeno | first2 = Y. | last3 = Iwasa | first3 = M. | last4 = Matoba | first4 = R. | last5 = Nagao | first5 = M. | title = Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry. | journal = Forensic Sci Int | volume = 113 | issue = 1–3 | pages = 367–73 |date=Sep 2000 | doi =  10.1016/S0379-0738(00)00226-7| pmid = 10978650 }}</ref> [[sedative]]<ref>{{Cite journal | last1 = Brisse | first1 = B. | last2 = Tetsch | first2 = P. | last3 = Toye | first3 = A. | title = [Clinical study on stress protective action of cloxazolam in jaw surgery in double blind comparison to placebo (author's transl)] | journal = Arzneimittelforschung | volume = 30 | issue = 4 | pages = 679–82 | year = 1980 | doi =  | pmid = 6104969 }}</ref> and [[skeletal muscle relaxant]] properties.<ref>{{Cite journal  | last1 = Ansseau | first1 = M. | last2 = von Frenckell | first2 = R. | title = Controlled comparison of two anxiolytic benzodiazepines, cloxazolam and bromazepam | journal = Neuropsychobiology | volume = 24 | issue = 1 | pages = 25–9 | year =  1990| doi =  10.1159/000119038| pmid = 1983433 }}</ref>

==Indications==
Cloxazolam's main use is as an anti-anxiety drug.<ref>{{Cite journal | last1 = Fischer-Cornelssen | first1 = KA. | title = Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug | journal = Arzneimittelforschung | volume = 31 | issue = 10 | pages = 1757–65 | year = 1981 | pmid = 6119092 }}</ref>

==Side effects==
An increased heart rate may occur as an adverse effect of cloxazolam.<ref>{{Cite journal  | last1 = Boucsein | first1 = W. | last2 = Wendt-Suhl | first2 = G. | title = [Psychological and physiological effects of cloxazolam and diazepam under anxiety-evoking and control conditions on healthy subjects (author's transl)] | journal = Pharmacopsychiatria | volume = 15 | issue = 2 | pages = 48–56 |date=Mar 1982 | doi =  10.1055/s-2007-1019508| pmid = 6123123 }}</ref>

==Pharmacology==
The pharmacological effects of cloxazolam are a result of mainly its [[active metabolites]], thus cloxazolam is a [[prodrug]]. The main site of action of cloxazolam and its active metabolites are the [[benzodiazepine receptor]].<ref>{{Cite journal  | last1 = Nakatsuka | first1 = I. | last2 = Shimizu | first2 = H. | last3 = Asami | first3 = Y. | last4 = Katoh | first4 = T. | last5 = Hirose | first5 = A. | last6 = Yoshitake | first6 = A. | title = Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity | journal = Life Sci | volume = 36 | issue = 2 | pages = 113–9 |date=Jan 1985 | pmid = 2857046  | doi = 10.1016/0024-3205(85)90089-X }}</ref>

The [[pharmacological]] actions of benzodiazepines at the [[GABAA receptor|GABA<sub>A</sub> receptor]] are similar to those of [[neurosteroids]]. [[Neuroactive]] steroids are positive [[allosteric]] modulators of the GABA<sub>A</sub> receptor, enhancing [[GABA]] function and in turn have effects on mood and other functions. Many benzodiazepines ([[diazepam]], [[medazepam]], [[estazolam]], [[temazepam]], [[flunitrazepam]] and nitrazepam) potently inhibit the [[enzymes]] involved in the [[metabolism]] of neurosteroids. The tetrahydroxazole ring that cloxazolam and [[oxazolam]] have decreases the [[inhibitory]] potency of benzodiazepines on neurosteroids. Thus there could be subtle differences between cloxazolam and other benzodiazepines.<ref>{{cite journal|author=Usami N |author2=Yamamoto T |author3=Shintani S |author4=Ishikura S |author5=Higaki Y |author6=Katagiri Y |author7=Hara A. |date=Apr 2002 |title=Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines |journal=Biol Pharm Bull. |volume=25 |issue=4 |pages=441–5 |pmid=11995921 |url=http://www.jstage.jst.go.jp/article/bpb/25/4/441/_pdf |format=pdf |doi=10.1248/bpb.25.441 }}{{dead link|date=November 2016 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> However, because the parent prodrugs of cloxazolam and oxazolam were tested rather than the active metabolites, this is purely speculative.

==See also==
* [[Cinazepam]]
* [[Gidazepam]]

==References==
{{Reflist|2}}

==External links==
* [http://www.inchem.org/documents/pims/pharm/pim923.htm Inchem.org - Cloxazolam]

{{Anxiolytics}}
{{Benzodiazepines}}
{{GABAAR PAMs}}

[[Category:Anxiolytics]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Lactams]]
[[Category:Oxazolobenzodiazepines]]
[[Category:Prodrugs]]